Hepatitis C prevalence in persons with mental retardation

Public Health Reviews

Volumn 26, Issue 4, 1998, Pages 311-316

  Merrick, Joav ^a  

^a DIVISION FOR INTELLECTUAL AND DEVELOPMENTAL DISABILITIES   (Israel)

Author keywords

Developmental disability; Hepatitis C; Institutions; Israel; Mental retardation

Indexed keywords

HEPATITIS C ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; ISRAEL; MAJOR CLINICAL STUDY; MALE; MENTAL DEFICIENCY; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD; SERODIAGNOSIS;

ADOLESCENT; ADULT; AGED; CHILD; DISABLED PERSONS; FEMALE; HEPATITIS C; HUMANS; INSTITUTIONALIZATION; ISRAEL; MALE; MENTAL RETARDATION; MIDDLE AGED; PREVALENCE; PUBLIC HEALTH;

EID: 0032232593     PISSN: 03010422     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Dienstag JL, Isselbacher KJ. Acute viral hepatitis. In: Fauci AS et al., eds. Harrison's principles of internal medicine. 14th ed. New York: McGraw-Hill, 1998: 1677-1692.
2. Heintges T, Wands JR. Hepatitis C virus: epidemiology and transmission. Hepatology 1997, 26: 521-526.
3. Christensen PB. Hepatitis C epidemiology. Ugeskr Laeger 1998; 160: 3529-3532 [in Danish].
4. Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA, Kaslow RA, Margolis HS. The prevalence of hepatitis C virus infection in the United States. N Engl J Med 1999; 341: 556-562.
5. Hansen HL, Andersen PL, Brandt L, Brolos O. Antibodies against hepatitis viruses in merchant seamen. Scand J Infect Dis 1995; 27: 191-194.
6. Nelsing S, Wantzin P, Skot J, Krarup E, Nielsen TL, Krarup HB et al. The seroprevalence of hepatitis B and C in hospitalized Danish patients. Scand J Infect Dis 1995; 27: 445-448.
7. Almog R, Low M, Cohen D, Robin G, Ashkenazi S, Bercovier H et al. Prevalence of anti-hepatitis A antibodies, hepatitis B viral markers and anti-hepatitis C antibodies among immigrants from the former USSR, who arrived in Israel during 1990-91. Infection 1999; 27: 212-217.
8. Shemer-Avni Y, el Astal Z, Kemper O, el Najjar KJ, Yaari A, Hanuka N et al. Hepatitis C virus infection and genotypes in Southern Israel and the Gaza Strip. J Med Virol 1998; 56: 230-233.
9. Levinson WM, Wormser GP, Forseter G, Calmann M, O'Brien TA. Hepatitis C virus seroprevalence in the developmentally disabled. Arch Intern Med 1992, 152: 2309-2311.
10. Chaudhary RK, Perry E, Hicks F, MacLean C, Morbey M. Hepatitis B and C infection in an institution for the developmentally handicapped. N Engl J Med 1992, 327: 1953.
11. Cunningham SJ, Cunningham R, Izmeth MG, Baker B, Hart CA. Seroprevalence of hepatitis B and C in a Merseyside hospital for the mentally handicapped. Epidemiol Infect 1994; 112: 195-200.
12. Cramp ME, Grundy HC, Perinpanayagam RM, Barnado DE. Seroprevalence of hepatitis B and C in two institutions caring for mentally handicapped adults. J R Soc Med 1996; 89: 401-402.
13. Arnedo A, Latorre MD, Pac MR, Safont L, Guillen F, Aguinaga I. Hepatitis A, B and C in an occupational center for the mentally handicapped. Enferm Infecc Microbiol Clin 1998; 16: 370-373 [in Spanish].
14. Lunding S, Hansen KS, Krogsgaard K, Rosdahl N, Smith E, Wantzin PS. Prevalence of hepatitis B and C among mentally retarded persons. Ugeskr Laeger 1999; 161: 4393-4396 (in Danish].
15. Pregliasco F, Conti A. Prevalence of anti-HCV in institutionalized mentally handicaped subjects. Eur J Epidemiol 1994; 1: 113-114.